Moleculin Biotech, Inc. (MBRX) › Total AssetsMoleculin Biotech, Inc. (MBRX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2015: $28.1K2016: $16.39M2017: $19.48M2018: $19.59M2019: $25.23M2020: $29.03M2021: $84.09M2022: $57.42M2023: $38.22M2024: $16.93M2025: $22.13M$22.13M2015Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$22.13M+30.7%2024$16.93M-55.7%2023$38.22M-33.4%2022$57.42M-31.7%2021$84.09M+189.7%2020$29.03M+15.0%2019$25.23M+28.8%2018$19.59M+0.5%2017$19.48M+18.8%2016$16.39M+58256.8%2015$28.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share